Furthermore, we explore how the ATX-LPA pathway impacts obesity and obesity-associated disorders, including impaired glucose homeostasis, insulin resistance, and cardiovascular disease. The gene discussed is LPA; the disease is obesity due to melanocortin 4 receptor deficiency.